INTEGRATION+ is an implementation research focused on malaria in pregnancy, with the potential to change national health prevention policies to protect an additional 13 million pregnant women each year from malaria. A consortium of universities and research institutions from 6 African countries and 2 European countries applied to fund this project to European Commission (EDCTP) and USA (PMI).
The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone,
In Africa, pregnant women and young children are the most vulnerable to malaria. However, malaria control interventions and strategies have achivied important results in the last years. COVID-19 has now
Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including